stockrowNuwellis, Inc.
NUWENuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024.
- Revenue
- +14.1%
- EPS
- +98.8%
- Free cash flow
- −51.6%
Quarter to June 2026, against a year earlier
Follow NUWE
Alert me
Nuwellis, Inc. (NUWE) EV/Sales
As of 6 November 2026, Nuwellis, Inc. (NUWE) trades at a EV/Sales of 0.0×. Over the past ten years it has ranged from −0.6× (September 2023) to 357,124,351,397,036× (February 2015); the current reading is higher than 4% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.5× | 1,217.11% |
| FY2024 | 0.0× | 116.18% |
| FY2023 | 0.0× | (100.00%) |
| FY2022 | 11,086× | (78.30%) |
| FY2021 | 51,090× | (99.36%) |
| FY2020 | 7,947,077× | 307.33% |
| FY2019 | 1,951,011× | (97.72%) |
| FY2018 | 85,588,590× | (17.65%) |
| FY2017 | 103,927,550× | (98.94%) |
| FY2016 | 9,819,696,212× | (99.67%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.1× | (86.00%) |
| Mar 2026 | 0.5× | (6.17%) |
| Dec 2025 | 0.5× | 8.50% |
| Sep 2025 | 0.5× | 144.61% |
| 37 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ICCM IceCure Medical Ltd. compare | −3.8× |
| CODX Co-Diagnostics, Inc. compare | −3.5× |
| AIDX 20/20 Biolabs Inc. compare | −0.7× |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| AMIX Autonomix Medical, Inc. compare | n/m |
| NUWE Nuwellis, Inc. | 0.0× |
| IVF INVO Fertility, Inc compare | 0.2× |
| VVOS Vivos Therapeutics, Inc. compare | 0.4× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)